atenolol has been researched along with Sweat Gland Diseases in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Sweat Gland Diseases: Diseases of the SWEAT GLANDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe the dermatological consequences of treatment with a beta-adrenergic antagonist, atenolol, in a patient with pheochromocytoma." | 3.67 | Sweat-gland necrosis after beta-adrenergic antagonist treatment in a patient with pheochromocytoma. ( Derom, E; Naeyaert, JM; Rubens, R; Santosa, S, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naeyaert, JM | 1 |
| Derom, E | 1 |
| Santosa, S | 1 |
| Rubens, R | 1 |
1 other study available for atenolol and Sweat Gland Diseases
| Article | Year |
|---|---|
Sweat-gland necrosis after beta-adrenergic antagonist treatment in a patient with pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Atenolol; Female; Humans; Necrosis; Pheochromocytoma; Sweat Gland Di | 1987 |